Drug-labels.com

Apo-Risedronate (Apotex, 35 mg): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
35 mg

Patient Medication Information: uses, side effects, how to take - Apo-Risedronate (Apotex, 35 mg)

What is APO-RISEDRONATE used for?

APO-RISEDRONATE is used in adults to:

  • treat or prevent osteoporosis in postmenopausal women.
  • increase bone density in men with osteoporosis.

How does APO-RISEDRONATE work?

APO-RISEDRONATE contains the medicinal ingredient risedronate sodium. Risedronate sodium belongs to a class of non-hormonal drugs called bisphosphonates. Bisphosphonates are similar to a molecule naturally made in your body that breaks down bone tissue. APO-RISEDRONATE binds to the receptors in your body to prevent the bone from breaking down. This slows down bone loss which can help to reduce the risk of fractures. In many people APO-RISEDRONATE helps to increase bone density.

What are the ingredients in APO-RISEDRONATE?

Medicinal ingredient: risedronate sodium hemi-pentahydrate

Non-medicinal ingredients: anhydrous lactose, colloidal silicon dioxide, crospovidone, hydroxypropyl cellulose, hydroxypropyl methylcellulose, magnesium stearate, polyethylene glycol, red ferric oxide, titanium dioxide and yellow ferric oxide.

APO-RISEDRONATE comes in the following dosage forms:

Film-coated tablets: 35 mg (orange)

Do not use APO-RISEDRONATE if:

  • you have low levels of calcium in your blood (hypocalcemia).
  • you are allergic to risedronate sodium or any of the other ingredients in APO-RISEDRONATE (see What are the ingredients in APO-RISEDRONATE?).

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take APO-RISEDRONATE. Talk about any health conditions or problems you may have, including if you:

  • have or have had problems swallowing or have problems with your esophagus (the tube that connects your mouth to your stomach)
  • have or have had stomach or digestive problems
  • have or have had kidney problems
  • cannot stand or sit upright for at least 30 minutes (see How to take APO-RISEDRONATE)
  • are pregnant or breastfeeding

  • have one of the following risk factors for developing osteonecrosis (bone damage in the jaw):

    • have cancer and/or are currently receiving chemotherapy
    • are currently having or have had radiotherapy of the head or neck
    • have an infection or a lowered immune system (immunosuppression)
    • are taking corticosteroids (used to treat inflammation) or cancer drugs such as angiogenesis inhibitors (used to slow down the growth of new blood vessels).
    • have diabetes (high blood sugar)
    • have poor oral hygiene or dentures that do not fit well
    • have or have had pain, swelling or numbness of the jaw or loosening of a tooth
    • have sores in your mouth. Your healthcare professional may tell you not to take APO-RISEDRONATE until all the sores in your mouth have healed.
    • are or have been a smoker
    • have or have had poor dental health, teeth or gum disease
    • have anemia (low red blood cell count)
    • have a blood disorder where your blood cannot form clots in the normal way
  • are lactose intolerant or have one of the following rare hereditary diseases:

    • Galactose intolerance
    • Lapp lactase deficiency
    • Glucose-galactose malabsorption

Because lactose is a non-medicinal ingredient in the 35 mg APO-RISEDRONATE tablets.

Other warnings you should know about:

Gastrointestinal Problems: Taking APO-RISEDRONATE incorrectly may cause you to experience problems with your esophagus. Stop taking APO-RISEDRONATE and talk to your healthcare professional if you experience difficulty or pain upon swallowing, chest/breastbone pain or new or worsening heartburn. To avoid problems with your esophagus and to allow the drug to reach the stomach, consider the following instructions:

  • swallow each tablet of APO-RISEDRONATE with a full glass of water.
  • do NOT chew or suck the tablet.
  • do NOT lie down for at least 30 minutes after taking APO-RISEDRONATE or until you have had your first meal of the day.
  • do NOT take APO-RISEDRONATE at bedtime or before starting your day.

Eye Problems: Drugs like APO-RISEDRONATE may cause vision problems. Different parts of your eye may experience inflammation or you may develop an eye infection. Your healthcare professional may end your treatment if they see symptoms of inflammation.

Oral Health: Your healthcare professional should check your mouth and may ask you to see your dentist before you start taking APO-RISEDRONATE. Dental work should be done before you start treatment with APO-RISEDRONATE. Tell your healthcare professional if you recently had any major dental procedures like an extraction or a root canal. Take good care of your teeth and gums and see the dentist for regular checkups while taking APO-RISEDRONATE.

Calcium and Vitamin D: Calcium and vitamin D are also important for strong bones. Your healthcare professional may ask you to take calcium and vitamin D while you are on APO-RISEDRONATE.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with APO-RISEDRONATE:

  • Vitamins, mineral supplements and antacids may contain substances that can stop your body from absorbing APO-RISEDRONATE. They include calcium, magnesium, aluminum and iron. Take these medicines at a different time of day than APO-RISEDRONATE. Talk to your healthcare professional about how and when to take these medications.
  • Taking APO-RISEDRONATE with corticosteroids or cancer drugs like angiogenesis inhibitors may increase your chance of jaw bone problems (osteonecrosis of the jaw).
  • Talk to your healthcare professional before taking pain medication like ASA or other non-steroidal anti-inflammatory drugs(NSAIDs) because they may upset your stomach.

How to take APO-RISEDRONATE:

  • Take APO-RISEDRONATE exactly as your healthcare professional tells you to.
  • Take APO-RISEDRONATE in the morning on an empty stomach, at least 30 minutes before you eat, drink or take other medicines.

  • Swallow each APO-RISEDRONATE tablet whole, while you are sitting or standing in an upright position. Drink enough plain water (at least 120 mL or ½ cup) to make sure the tablet gets to your stomach. Do not chew, cut or crush the tablets.
  • Do not lie down for at least 30 minutes after taking APO-RISEDRONATE.

Usual dose:

To treat osteoporosis in women after menopause:

  • 1 tablet (35 mg) per week of APO-RISEDRONATE

To prevent osteoporosis in women after menopause:

  • 1 tablet (35 mg) per week of APO-RISEDRONATE

To increase bone density in men with osteoporosis:

  • 1 tablet (35 mg) per week of APO-RISEDRONATE

Overdose:

If you take too much APO-RISEDRONATE, drink a full glass of milk and tell your healthcare professional immediately. Do not make yourself vomit. Do not lie down.

If you think you, or a person you are caring for, have taken too much APO-RISEDRONATE, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

Weekly dose (35 mg):

If you missed your dose on your usual day, take one tablet in the morning after you remember. You can go back to your regular schedule for the next dose. If you have missed your dose by one week, do not take 2 tablets on the same day. Skip your missed dose and go back to your regular schedule.

What are possible side effects from using APO-RISEDRONATE?

These are not all the possible side effects you may have when taking APO-RISEDRONATE. If you experience any side effects not listed here, tell your healthcare professional.

Side effects may include:

  • abdominal pain, heartburn, nausea
  • diarrhea
  • constipation
  • flatulence (gas)
  • headache
  • lack of energy

When you take APO-RISEDRONATE once a month, it may cause short-lasting, mild flu-like symptoms. These symptoms usually decrease as you keep taking doses.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
COMMON
Pain in bones, joints or muscles
  • ✓
Esophagus and stomach problems: abdominal pain, pain or trouble swallowing, vomiting blood, heartburn, chest or breastbone pain, black or bloody stool
  • ✓
UNCOMMON
Eye problems: eye pain, redness or swelling, sensitivity to light, decreased vision.✓
RARE
Pain in your tongue✓

Jaw bone problems (osteonecrosis):

numbness or a feeling of heaviness in the jaw; poor healing of gums; loose teeth; exposed bone in the mouth; sores in the mouth; discharge; dry mouth; swelling gums; infections; bad breath; pain in the mouth, teeth or jaw.

✓
VERY RARE
Allergic reactions: hives, rash (with or without blisters); swelling of the face, lips, tongue or throat; difficult or painful swallowing; trouble breathing.✓
Hypocalcemia (low levels of calcium in the blood): numbness, tingling or muscle spasms✓
Atypical femur fractures: new or unusual pain in the hip, groin or thigh✓

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

  • Keep APO-RISEDRONATE in the original package and store at controlled room temperature (15°C to 30°C).
  • Keep out of reach and sight of children.

If you want more information about APO-RISEDRONATE:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html); the manufacturer’s website http://www.apotex.ca/products, or by calling 1-800-667-4708.

Last Revised: JUN 23, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02353687

Revision date stated in the text: June 23, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Apo-Risedronate (Apotex, 35 mg)

Rx or OTC
Prescription (Rx)?
DIN 02353687
Schedule(s) PRESCRIPTION
Active ingredient(s) Risedronate sodium (risedronate sodium hemipentahydrate) 35 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. M Musculo-skeletal system drugs
    1. M05 Drugs for treatment of bone diseases
      1. M05B Drugs affecting bone structure and mineralization
        1. M05BA Bisphosphonate drugs affecting bone structure and mineralization
          1. M05BA07 Risedronic acid
Company APOTEX INC
Current status Marketed
Current status date June 20, 2012

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.